These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 6697964)

  • 1. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
    Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
    Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ; Jordan VC
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol-stimulated increases in uterine eosinophils and nuclear type II estrogen-binding sites are prevented by pertussis toxin.
    Lyttle CR; Teuscher C; Medlock KL; Sheehan DM
    Endocrinology; 1989 Nov; 125(5):2773-9. PubMed ID: 2792007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estradiol-17 alpha on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth.
    Clark JH; Williams M; Upchurch S; Eriksson H; Helton E; Markaverich BM
    J Steroid Biochem; 1982 Feb; 16(2):323-8. PubMed ID: 7078167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
    Ferguson ER; Katzenellenbogen BS
    Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential response of individual uterine cell types from immature rats treated with estradiol.
    McCormack SA; Glasser SR
    Endocrinology; 1980 May; 106(5):1634-49. PubMed ID: 6153974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response.
    Markaverich BM; Clark JH
    Endocrinology; 1979 Dec; 105(6):1458-62. PubMed ID: 574077
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
    Gardner RM; Kirkland JL; Stancel GM
    Endocrinology; 1978 Nov; 103(5):1583-9. PubMed ID: 748005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrete early changes in cellular subpopulations of rat uterine and anterior pituitary estrogen receptors in response to acute exposure to exogenous estradiol.
    Copland JA; Smanik EJ; Muldoon TG
    J Steroid Biochem; 1987 Jun; 26(6):723-31. PubMed ID: 3613573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
    Attardi B; Palumbo LA
    Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal treatment with sex steroids: relationship between the uterotropic response and the estrogen "receptor" in prepubertal rats.
    Gellert RJ; Lewis J; Pétra PH
    Endocrinology; 1977 Feb; 100(2):520-8. PubMed ID: 12934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen action in the mouse uterus: adrenal modulation of receptor levels.
    Quarmby VE; Fox-Davies C; Swaisgood MH; Korach KS
    Endocrinology; 1982 Apr; 110(4):1208-16. PubMed ID: 7060522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen regulation of prolactin gene transcription in vivo: paradoxical effects of 17 beta-estradiol dose.
    Shull JD; Gorski J
    Endocrinology; 1989 Jan; 124(1):279-85. PubMed ID: 2909367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen action in the mouse uterus: the influence of the neuroendocrine-adrenal axis.
    Quarmby VE; Fox-Davies C; Korach KS
    Endocrinology; 1984 Jan; 114(1):108-15. PubMed ID: 6690267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimodal nuclear estrogen receptor binding: synchrony in athymic mouse uterus and human breast tumor xenografts.
    Beckman WC; Hudspeth DA; Golding T; Hubbert L; Akkerman J; Korach KS
    Endocrinology; 1989 Jun; 124(6):2651-8. PubMed ID: 2721439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.